Skip to main content
Premium Trial:

Request an Annual Quote

Two Cancer Research Teams Split $400K Nvidia Foundation Award

NEW YORK (GenomeWeb) – Separate research teams from the Dana-Farber Cancer Institute and Stanford University have received $200,000 grants from the Nvidia Foundation to support their efforts to apply computational methods to cancer research.

The awards come from Nvidia Foundation’s Compute the Cure effort, which supports projects that use parallel computing technology to yield breakthroughs in cancer treatment and diagnostics. The grant awardees were chosen by a panel of Nvidia employees, with support from researchers at the National Cancer Institute.

The team led by John Quackenbush, a professor of biostatistics and computational biology at Dana-Farber, hopes to identify more effective cancer therapies by analyzing tumor and clinical data collected from Dana-Farber patients. The group wants to use graphics processing units to speed up its search for patterns in data that could ultimately be linked to new treatments, and will also explore genetic similarities across different cancer types to see if treatments used for specific types of cancer could be repurposed to treat other forms of the disease.

Meantime, the team led by Vijay Pande, a professor of chemistry, structural biology, and computer science at Stanford, is seeking to use a combination of molecular simulation and machine learning techniques, and the user network of the [email protected] software program, a tool that simulates how proteins in the body assemble themselves, to better understand and predict tumor mutations in breast cancer patients with an eye towards identifying more effective therapies for the disease as well as other forms of cancer.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.